Fremanezumab [1655501-53-3]

TargetMol Chemicals

Fremanezumab

9

1655501-53-3

Antibody

Research Use Only

Fremanezumab

Fremanezumab (TEV-48125), a humanized IgG2a monoclonal antibody, potently and selectively targets the calcitonin gene-related peptide (CGRP), a 37-amino acid neuropeptide implicated in the central and peripheral mechanisms of migraine. It holds promise for research into chronic migraine treatment [1].

3 years

-20°C

12352203